5 Reasons Tell You Why You Need Total PCR Solution

Company news
2022-03-15

Omicron reshapes the world we are living in.

 

The COVID-19 crisis has affected global economies in the past two years. At the end of 2021, a new coronavirus variant - Omicron took the world by storm and lead to more COVID-19 cases and can spread the virus to others, even if they are vaccinated or don’t have symptoms. However, according to data, Omicron leads to low fatality due to more vaccination rates. Scientists even make a forecast that SARS-CoV-2 will become a common virus as influenza and coronavirus and permanently reshape our world as it continues to unfold.

 

What is the way out for PCR laboratory?

 

RT-PCR technology remains to be a sensitive testing method to detect SARS-CoV-2. PCR laboratory played a major role in the early diagnosis of SARS-CoV-2. However, with the Omicron becoming less severe and milder, the testing capacity of COVID-19 might encounter a slight decline as the vaccination rate grows. Under such a situation, the daily screening of other infectious diseases' panels will be a way out.

In this regard, Bioperfectus “3 ‘Ones’ Total PCR Solution” will satisfy the demands of different PCR labs for 5 reasons.

 

One Solution, One Supplier, One Response

 

 

1.      One call to solve it all.

 

Many PCR laboratories will face one headache when an abnormal PCR result occurs. Many times, it might be a problem of some certain reagent or system, however, it won’t be if you have too many different “brands” in your labs. No time for troubleshooting? Wait for too long for one single problem? Just make one call to Bioperfectus, we will solve it all.

2.      Extensive test panels for long-term growth.

We provide customized solutions for different infectious disease panels, not only for COVID-19, but also for influenza, Measles, Rubella, HPV, STD, and so on. No need to buy new instruments for different infectious diseases and prepare for the sudden attack by COVID-19. With over 12 years of specialized experience in infectious diseases diagnosis, we are prepared for a comprehensive infectious disease spectrum.

3.      Approach to low to high sample throughputs laboratories.

As a one-stop solution provider for whole operations of PCR procedure, we have different throughput instruments to satisfy various testing scenarios. Soon we will launch instruments with cap management, samples loading functions which will decrease manual operations. With Bioperfectus, you will have the approach to low to high sample throughputs laboratories, and also continuously update the automatic level of operation.

4.      Quality assurance by full validation in-house.

During indoor development, we validated the whole system with reagents and instruments from extraction to PCR analysis. Bioperfectus total PCR solution will convince laboratorieswith reassuring results.

5. One solution for product, training, services, and marketing.

As a total solution supplier, we provide not only products but also product-related training, services, and marketing. Together with Bioperfectus, we can have a professional service and sales team to satisfy the clinical’s demand. 

 

Bioperfectus is devoted to providing holistic molecular diagnostic products and services with high-quality and excellent performance. Our overseas teams stayed close with laboratories during the difficult period of the COVID-19 pandemic. We will continue bringing automation and versatile solutions in infectious diseases diagnostic management and help the labs to prepare for future daily detection.

MOST READ

Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.

2022-11-30

Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.

2022-11-15

Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).

2022-11-14